These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28537437)

  • 21. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
    Elleri D; Acerini CL; Allen JM; Hayes J; Pesterfield C; Wilinska ME; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2010 Jan; 12(1):35-9. PubMed ID: 20082583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescents' Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study.
    Rankin D; Kimbell B; Allen JM; Besser REJ; Boughton CK; Campbell F; Elleri D; Fuchs J; Ghatak A; Randell T; Thankamony A; Trevelyan N; Wilinska ME; Hovorka R; Lawton J
    J Diabetes Sci Technol; 2021 Sep; 15(5):1042-1051. PubMed ID: 34261348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.
    Elleri D; Allen JM; Biagioni M; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Pediatr Diabetes; 2012 Sep; 13(6):449-53. PubMed ID: 22817340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 28. Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.
    Lawton J; Blackburn M; Rankin D; Werner C; Farrington C; Hovorka R; Hallowell N
    AJOB Empir Bioeth; 2019; 10(2):100-112. PubMed ID: 30986113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp.
    Ly TT; Keenan DB; Roy A; Han J; Grosman B; Cantwell M; Kurtz N; von Eyben R; Clinton P; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2016 Jun; 18(6):377-84. PubMed ID: 27183197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid closed-loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with type 1 diabetes.
    Roberts A; Fried L; Dart J; de Bock M; Fairchild J; King B; Ambler GR; Cameron F; McAuley SA; Keech AC; Jenkins A; O Neal DN; Davis EA; Jones TW; Abraham MB;
    Diabet Med; 2022 Sep; 39(9):e14907. PubMed ID: 35757899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents.
    Barnard KD; Wysocki T; Allen JM; Elleri D; Thabit H; Leelarathna L; Gulati A; Nodale M; Dunger DB; Tinati T; Hovorka R
    BMJ Open Diabetes Res Care; 2014; 2(1):e000025. PubMed ID: 25452866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes.
    Thabit H; Elleri D; Leelarathna L; Allen J; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska M; Barnard K; Heller S; Amiel S; Evans M; Dunger D; Hovorka R
    Lancet; 2015 Feb; 385 Suppl 1():S96. PubMed ID: 26312919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A qualitative study exploring the expectations of people living with type 1 diabetes regarding prospective use of a hybrid closed-loop system.
    Quintal A; Messier V; Rabasa-Lhoret R; Racine E
    Diabet Med; 2020 Nov; 37(11):1832-1840. PubMed ID: 32298490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.